Synaptic transmission changes in fear memory circuits underlie key features of an animal model of schizophrenia

Behavioural Brain Research

Volumn 227, Issue 1, 2012, Pages 184-193

  Pollard, Marie ^a   Varin, Christophe ^a   Hrupka, Brian ^a   Pemberton, Darrel J ^a   Steckler, Thomas ^a   Shaban, Hamdy ^a  

^a JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

Author keywords

Amygdala; Extinction; LTP; NMDA; Parvalbumin; Phencyclidine

Indexed keywords

AMPA RECEPTOR; GLUTAMATE DECARBOXYLASE 67; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PARVALBUMIN; PHENCYCLIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN FUNCTION; BRAIN NERVE CELL; CONTROLLED STUDY; ELECTROPHYSIOLOGY; FEAR; HIPPOCAMPAL CA1 REGION; HIPPOCAMPUS; LATERAL AMYGDALA; LEARNING; LONG TERM POTENTIATION; MALE; MEMORY; NERVE CELL NETWORK; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; SCHIZOPHRENIA; SYNAPTIC TRANSMISSION;

ACTION POTENTIALS; AMYGDALA; ANIMALS; AREA UNDER CURVE; BIOPHYSICS; DISEASE MODELS, ANIMAL; ELECTRIC STIMULATION; EXCITATORY AMINO ACID ANTAGONISTS; EXCITATORY POSTSYNAPTIC POTENTIALS; EXTINCTION, PSYCHOLOGICAL; FEAR; GLUTAMATE DECARBOXYLASE; HIPPOCAMPUS; MALE; MEMORY DISORDERS; NEURONS; PARVALBUMINS; PATCH-CLAMP TECHNIQUES; PHENCYCLIDINE; QUINOXALINES; RATS; RATS, LONG-EVANS; RATS, SPRAGUE-DAWLEY; SCHIZOPHRENIA; SYNAPTIC TRANSMISSION; TIME FACTORS;

EID: 82455172121     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2011.10.050     Document Type: Article

References (50)

1. Abekawa T., Ito K., Nakagawa S., Koyama T. Prenatal exposure to an NMDA receptor antagonist, MK-801 reduces density of parvalbumin-immunoreactive GABAergic neurons in the medial prefrontal cortex and enhances phencyclidine-induced hyperlocomotion but not behavioral sensitization to methamphetamine in postpubertal rats. Psychopharmacology 2007, 192:303-316.
2. Amitai N, Kuczenski R, Behrens MM, Markou A. Repeated phencyclidine administration alters glutamate release and decreases GABA markers in the prefrontal cortex of rats. Article, , in press. doi:10.1016/j.neuropharm.2011.01.008.
3. Bast T., Zhang W-N., Feldon J. The ventral hippocampus and fear conditioning in rats. Exp Brain Res 2001, 139:39-52.
4. Bauer E.P., Schafe G.E., LeDoux J.E. NMDA receptors and l-Type voltage-gated calcium channels contribute to long-term potentiation and different components of fear memory formation in the lateral amygdala. J Neurosci 2002, 22:5239-5249.
5. Benes F.M. Amygdalocortical circuitry in schizophrenia: from circuits to molecules. Neuropsychopharmacology 2010, 35:239-257.
6. Benes F.M., Berretta S. Amygdalo-entorhinal inputs to the hippocampal formation in relation to schizophrenia. Ann N Y Acad Sci 2006, 911:293-304.
7. Díaz-Mataix L., Debiec J., LeDoux J.E., Doyère V. Sensory-specific associations stored in the lateral amygdala allow for selective alteration of fear memories. J Neurosci 2011, 31:9538-9543.
8. duBois T.M., Deng C., Han M., Newell K.A., Huang X.F. Excitatory and inhibitory neurotransmission is chronically altered following perinatal NMDA receptor blockade. Eur Neuropsychopharmacol 2009, 19:256-265.
9. Ehrlich I., Humeau Y., Grenier F., Ciocchi S., Herry C., Lüthi A. Amygdala inhibitory circuits and the control of fear memory. Neuron 2009, 62:757-771.
10. Farb C.R., Aoki C., LeDoux J.E. Differential localization of NMDA and AMPA receptor subunits in the lateral and basal nuclei of the amygdala: a light and electron microscopic study. J Comp Neurol 1995, 362:86-108.
11. Gisabella B., Bolshakov V.Y., Benes F.M. Regulation of synaptic plasticity in a schizophrenia model. Proc Natl Acad Sci USA 2005, 102:13301-13306.
12. Grunze H.C., Rainnie D.G., Hasselmo M.E., Barkai E., Hearn E.F., McCarley R.W., et al. NMDA-dependent modulation of CA1 local circuit inhibition. J Neurosci 1996, 16:2034-2043.
13. Herry C., Ferraguti F., Singewald N., Letzkus J.J., Ehrlich I., Lüthi A. Neuronal circuits of fear extinction. Eur J Neurosci 2010, 31:599-612.
14. Holt D.J., Lebron-Milad K., Milad M.R., Rauch S.L., Pitman R.K., Orr S.P., et al. Extinction memory is impaired in schizophrenia. Biol Psychiatry 2009, 65:455-463.
15. Humeau Y., Herry C., Kemp N., Shaban H., Fourcaudot E., Bissière S., et al. Dendritic spine heterogeneity determines afferent-specific Hebbian plasticity in the amygdala. Neuron 2005, 45:119-131.
16. Humeau Y., Shaban H., Bissière S., Lüthi A. Presynaptic induction of heterosynaptic associative plasticity in the mammalian brain. Nature 2003, 426:841-845.
17. Javitt D.C., Zukin S.R. Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 1991, 148:1301-1308.
18. Jenkins T.A., Harte M.K., Reynolds G.P. Effect of subchronic phencyclidine administration on sucrose preference and hippocampal parvalbumin immunoreactivity in the rat. Neurosci Lett 2010, 471:144-147.
19. Johnson K.M., Jones S.M. Neuropharmacology of phencyclidine: basic mechanisms and therapeutic potential. Annu Rev Pharmacol Toxicol 1990, 30:707-750.
20. Kalinichev M., Robbins M.J., Hartfield E.M., Maycox P.R., Moore S.H., Savage K.M., et al. Comparison between intraperitoneal and subcutaneous phencyclidine administration in Sprague-Dawley rats: a locomotor activity and gene induction study. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32:414-422.
21. Kapur S., Seeman P. NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D2 and serotonin 5-HT2 receptors-implications for models of schizophrenia. Mol Psychaitry 2002, 7:837-844.
22. Kim J., Lee S., Park K., Hong I., Song B., Son G., et al. Amygdala depotentiation and fear extinction. Proc Natl Acad Sci USA 2007, 104:20955-20960.
23. Kim J.J., Lee H.J., Han J.S., Packard M.G. Amygdala is critical for stress-induced modulation of hippocampal long-term potentiation and learning. J Neurosci 2001, 21:5222-5228.
24. Klamer D., Zhang J., Engel J.A., Svensson L. Selective interaction of nitric oxide synthase inhibition with phencyclidine: behavioral and NMDA receptor binding studies in the rat. Behav Brain Res 2005, 159:95-103.
25. Krystal J.H., Karper L.P., Seibyl J.P., Freeman G.K., Delaney R., Bremner J.D., et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 1994, 51:199-214.
26. Li Q., Clark S., Lewis D.V., Wilson W.A. NMDA receptor antagonists disinhibit rat posterior cingulate and retrosplenial cortices: a potential mechanism of neurotoxicity. J Neurosci 2002, 22:3070-3080.
27. Maren S. Seeking a spotless mind: extinction, deconsolidation, and erasure of fear memory. Neuron 2011, 70:830-845.
28. McDonald A.J., Muller J.F., Mascagni F. Postsynaptic targets of GABAergic basal forebrain projections to the basolateral amygdala. Neuroscience 2011, 183:144-159.
29. McGuinness L., Taylor C., Taylor R.D.T., Yau C., Langenhan T., Hart M.L., et al. Presynaptic NMDARs in the hippocampus facilitate transmitter release at theta frequency. Neuron 2010, 68:1109-1127.
30. Melnick S.M., Rodriguez J.S., Bernardi R.E., Ettenberg A. A simple procedure for assessing ataxia in rats: effects of phencyclidine. Pharmacol Biochem Behav 2002, 72:125-130.
31. Monyer H., Burnashev N., Laurie D.J., Sakmann B., Seeburg P.H. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 1994, 12:529-540.
32. Mouri A., Noda Y., Enomoto T., Nabeshima T. Phencyclidine animal models of schizophrenia: approaches from abnormality of glutamatergic neurotransmission and neurodevelopment. Neurochem Int 2007, 51:173-184.
33. Nakao K., Matsuyama K., Matsuki N., Ikegaya Y. Amygdala stimulation modulates hippocampal synaptic plasticity. Proc Natl Acad Sci USA 2004, 101:14270-14275.
34. Neill J.C., Barnes S., Cook S., Grayson B., Idris N.F., McLean S.L., et al. Animal models of cognitive dysfunction and negative symptoms of schizophrenia: focus on NMDA receptor antagonism. Pharmacol Ther 2010, 128:419-432.
35. Nissen W., Szabo A., Somogyi J., Somogyi P., Lamsa K.P. Cell type-specific long-term plasticity at glutamatergic synapses onto hippocampal interneurons expressing either parvalbumin or CB1 cannabinoid receptor. J Neurosci 2010, 30:1337-1347.
36. Ou L.C., Yeh S.H., Gean P.W. Late expression of brain-derived neurotrophic factor in the amygdala is required for persistence of fear memory. Neurobiol Learn Mem 2010, 93:372-382.
37. Pitkänen A., Pikkarainen M., Nurminen N., Ylinen A. Reciprocal connections between the amygdala and the hippocampal formation, perirhinal cortex, and postrhinal cortex in rat. A review. Ann N Y Acad Sci 2000, 911:369-391.
38. Proksch J.W., Gentry W.B., Owens S.M. The effect of rate of drug administration on the extent and time course of phencyclidine distribution in rat brain, testis, and serum. Drug Metab Dispos 2000, 28:742-747.
39. Rasetti R., Mattay V.S., Wiedholz L.M., Kolachana B.S., Hariri A.R., Callicott J.H., et al. Evidence that altered amygdala activity in schizophrenia is related to clinical state and not genetic risk. Am J Psychiatry 2009, 166:216-225.
40. Richardson M.P., Strange B.A., Dolan R.J. Encoding of emotional memories depends on amygdala and hippocampus and their interactions. Nat Neurosci 2004, 7:278-285.
41. Sah P., Armentia M.L.D. Excitatory synaptic transmission in the lateral and central amygdala. Ann N Y Acad Sci 2003, 985:67-77.
42. Samson R.D., Dumont E.C., Paré D. Feedback inhibition defines transverse processing modules in the lateral amygdala. J Neurosci 2003, 23:1966-1973.
43. Shaban H., Humeau Y., Herry C., Cassasus G., Shigemoto R., Ciocchi S., et al. Generalization of amygdala LTP and conditioned fear in the absence of presynaptic inhibition. Nat Neurosci 2006, 9:1028-1035.
44. Sturgeon R.D., Fessler R.G., London S.F., Meltzer H.Y. Behavioral effects of chronic phencyclidine administration in rats. Psychopharmacology 1982, 76:52-56.
45. Ver Donck L, Duytschaever H, Willems R, Drinkenburg WH. Low dose subchronic phencyclidine (PCP)-pretreatment potentiates PCP-induced hyperlocomotion in adult rats.840.7. 2009 Neuroscience Meeting Planner. Chicago, IL: Society for Neuroscience, 2009. Online.
46. Wass C., Archer T., Pålsson E., Fejgin K., Klamer D., Engel J.A., et al. Effects of phencyclidine on spatial learning and memory: nitric oxide-dependent mechanisms. Behav Brain Res 2006, 171:147-153.
47. Xiao X., Dawson N., Macintyre L., Morris B.J., Pratt J.A., Watson D.G., et al. Exploring metabolic pathway disruption in the subchronic phencyclidine model of schizophrenia with the generalized singular value decomposition. BMC Syst Biol 2011, 5:e72.
48. Xue J.G., Masuoka T., Gong X.D., Chen K.S., Yanagawa Y., Law S.K., et al. NMDA receptor activation enhances inhibitory GABAergic transmission onto hippocampal pyramidal neurons via presynaptic and postsynaptic mechanisms. J Neurophysiol 2011, 105:2897-2906.
49. A synaptic receptors. Science 2002, 113:1-10.
50. Zhang Z.J., Reynolds G.P. A selective decrease in the relative density of parvalbumin-immunoreactive neurons in the hippocampus in schizophrenia. Schizophr Res 2002, 55:1-10.